entity

SDA-2026-04-01-gap-20260401-225155

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SDA-2026-04-01-gap-20260401-225155: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

16Connections
0Hypotheses
2Analyses
16Outgoing
0Incoming

Wiki Pages (20)

Knowledge base pages for this entity

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

CBS/PSP Supplements Guide

therapeutic · 6929 words

Device Therapies Comparison for CBS/PSP

therapeutic · 6867 words

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

therapeutic · 6350 words

CBS/PSP Treatment Rankings

therapeutic · 5434 words

Outgoing (16)

TargetRelationTypeStr
Gut-Brain Axisinvestigatesconcept0.95
Parkinsons Diseaserelevant_todisease0.95
h-e7e1f943generatedhypothesis0.95
h-74777459generatedhypothesis0.95
h-6c83282dgeneratedhypothesis0.95

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (2)

Scientific analyses that reference this entity

Do SCFAs directly modulate α-synuclein aggregation in vivo at physiologically re

neurodegeneration | 2026-04-12 | 2 hypotheses Top: 0.537

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

neurodegeneration | 2026-04-01 | 20 hypotheses Top: 0.617

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found